Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Indiziert in
  • Index Copernicus
  • Google Scholar
  • Öffnen Sie das J-Tor
  • Genamics JournalSeek
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • Elektronische Zeitschriftenbibliothek
  • RefSeek
  • Hamdard-Universität
  • EBSCO AZ
  • OCLC – WorldCat
  • Virtuelle Bibliothek für Biologie (vifabio)
  • Publons
  • Genfer Stiftung für medizinische Ausbildung und Forschung
  • Euro-Pub
  • ICMJE
Teile diese Seite

Abstrakt

Fright of Covid-19 and its Future: A Review

Debpratim Chakraborty and Nisha Lama Yolmo

From Dec 2019 the disease Covid-19 stated being epidemic in China and Outbreak throughout the world. WHO announced it pandemic on 11th Feb 2020.The most common symptoms of COVID-19 patients are fever, dry cough and tiredness.

There are mainly two broad categories of test for the diagnosis of Covid-19s, e.g. the RT-PCR test and Antibodies detection test. There is no specific treatment but the symptomatic treatment must be categorized like symptomatic treatment, oxygen therapy, treatment of co-infections, prevention of complications and septic shock.

The viral replication takes place after binding with the ACE2receptor, injecting the genome into the host cell, Translation and replication multiply the RNA based nuclear material. After that packaging is takes places and ultimately viral multiplication successfully completed in the presence of various enzymes. The replication can inhibit by blocking the receptor binding or by enzyme inhibition.

Several Clinical Trials and Researches are going on though out the world. A Chinese research team has found a compound called “11a” is less toxic and more effective. Another research said that Interferon-beta-1-b may be a key component for the treatment of COVID-19. Remdesivir, an Ebola drug shows 31% faster recovery than a placebo. Chinese based vaccine’s first human clinical trial was successful and Research on vaccine of Oxford University’s human clinical trial is going “very Well”.

In such a short time, we have advanced our knowledge and research about the virus and the disease a lot so in future we will must overcome and get a peaceful life.